In B16BL6 melanoma model, intratumorally delivery of an adenoviral vector encoding CCL27 and other chemokines (AdRGD), enhanced activated T cell recruitment and inhibited tumor growth, optimal antitumor efficacy may be achieved when combining with systemic effector T cell activation (123). This evidence concerns the gene CCL27 and melanoma.